Rudolf de Boer, RA de Boer

About Rudolf de Boer, RA de Boer

Rudolf de Boer, RA de Boer, With an exceptional h-index of 118 and a recent h-index of 97 (since 2020), a distinguished researcher at Rijksuniversiteit Groningen, specializes in the field of cardiology, heart failure, biomarkers, cardiac remodeling, galectin-3.

His recent articles reflect a diverse array of research interests and contributions to the field:

Effect of dapagliflozin versus placebo on symptoms and 6-minute walk distance in patients with heart failure: The determine randomized clinical trials

An increase in albuminuria is associated with a higher incidence of malignancies

Remote haemodynamic monitoring in patients with heart failure–Authors' reply

Advancing the fight against fibrosis in patients with heart failure: The contribution of sodium-glucose cotransporter 2 inhibition.

Unbiased complexome profiling and global proteomics analysis reveals mitochondrial impairment and potential changes at the intercalated disk in presymptomatic R14Delta/+ mice …

Associations of relative fat mass and BMI with all‐cause mortality: Confounding effect of muscle mass

Influence of stressful life events and personality traits on PLN cardiomyopathy severity: an exploratory study

Heart failure, investigator-reported sleep apnea and dapagliflozin: A patient-level pooled meta-analysis of DAPA-HF and DELIVER

Rudolf de Boer, RA de Boer Information

University

Position

Professor in Cardiology the Netherlands

Citations(all)

86774

Citations(since 2020)

67241

Cited By

39383

hIndex(all)

118

hIndex(since 2020)

97

i10Index(all)

458

i10Index(since 2020)

400

Email

University Profile Page

Google Scholar

Rudolf de Boer, RA de Boer Skills & Research Interests

cardiology

heart failure

biomarkers

cardiac remodeling

galectin-3

Top articles of Rudolf de Boer, RA de Boer

Effect of dapagliflozin versus placebo on symptoms and 6-minute walk distance in patients with heart failure: The determine randomized clinical trials

Circulation

2024/3/12

An increase in albuminuria is associated with a higher incidence of malignancies

Clinical Kidney Journal

2024/1/12

Remote haemodynamic monitoring in patients with heart failure–Authors' reply

The Lancet

2024/3/2

Advancing the fight against fibrosis in patients with heart failure: The contribution of sodium-glucose cotransporter 2 inhibition.

European Journal of Heart Failure

2024/1/9

Unbiased complexome profiling and global proteomics analysis reveals mitochondrial impairment and potential changes at the intercalated disk in presymptomatic R14Delta/+ mice …

bioRxiv

2024

Associations of relative fat mass and BMI with all‐cause mortality: Confounding effect of muscle mass

Obesity

2024/3

Influence of stressful life events and personality traits on PLN cardiomyopathy severity: an exploratory study

Europace

2024/1

Heart failure, investigator-reported sleep apnea and dapagliflozin: A patient-level pooled meta-analysis of DAPA-HF and DELIVER

Journal of Cardiac Failure

2024/3/1

Recreational and occupational physical activity and risk of adverse events in truncating MYBPC3 founder variant carriers

medRxiv

2024

RELEASE-HF study: a protocol for an observational, registry-based study on the effectiveness of telemedicine in heart failure in the Netherlands

BMJ open

2024/1/1

Early consequences of the phospholamban mutation PLN‐R14del+/− in a transgenic mouse model

Acta Physiologica

2024/3

Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER Malformation

2024/4/17

Mediators of the association between albuminuria and incident cancer: the PREVEND study

Clinical Kidney Journal

2024/1

Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice

Cardiovascular Research

2024/2/24

The plasma proteome is linked with left ventricular and left atrial function parameters in patients with chronic heart failure

European Heart Journal-Cardiovascular Imaging

2024/4/10

Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study

Heart Failure

2024/1/1

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence

2024/4/7

ECG-only Explainable Deep Learning Algorithm Predicts the Risk for Malignant Ventricular Arrhythmia in Phospholamban Cardiomyopathy

Heart Rhythm

2024/2/23

The year in cardiovascular medicine 2023: the top 10 papers in heart failure and cardiomyopathies

2024/2/14

Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER

JACC: Heart Failure

2024/4/3

See List of Professors in Rudolf de Boer, RA de Boer University(Rijksuniversiteit Groningen)